二维与三维超声造影监测肾癌消融后复发的长期随访
本研究纳入53例肾癌消融后超过8个月的患者,采用二维和三维超声造影(CEUS)进行复发监测,由三名不同经验水平的放射科医生评估增强特征并判断有无复发。结果显示复发表现为消融腔完全增强、到达时间与强度与肾皮质一致,所有读者检出复发的敏感度均为100%,特异度为90%-94%,加用三维CEUS未带来显著改善且降低读者信心。
要点
- 复发表现为消融腔完全增强,到达时间与强度与肾皮质一致
- 无复发表现为腔内完全无增强或自消融腔周边的延迟增强
- 所有读者检出复发敏感度100%,特异度90%-94%
核心结论
- CEUS在本研究中成功识别了所有肾癌复发病例,加用三维CEUS未获显著改善且降低读者信心。
- 部分治疗完全缓解的患者随时间出现消融腔周边延迟增强,对应脂肪坏死、瘢痕或肉芽组织。
研究设计与样本
- 经IRB批准的研究,53例肾癌消融后超过8个月的患者签署知情同意。
- 患者接受使用Optison(GE Healthcare)的二维和三维CEUS检查。
- 三名CEUS经验不同的放射科医生描述增强特征、判断有无复发并量化诊断信心。
主要发现
- 复发病例表现为消融腔完全增强,到达时间与强度与肾皮质一致。
- 无复发表现为消融腔内完全无增强,或自消融腔周边的延迟增强。
- 所有读者检出肾癌复发的敏感度为100%,特异度为90%-94%。
- 读者间一致率为88%至96%。
- 加用三维CEUS未取得显著改善,且其纳入导致读者信心下降。
临床怎么用
- 可将消融腔完全增强且到达时间与强度同肾皮质一致作为复发的CEUS征象。
- 消融腔周边延迟增强可对应脂肪坏死、瘢痕或肉芽组织,需注意与复发鉴别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate efficacy of using 2D and 3D contrast enhanced ultrasound (CEUS) for surveillance of RCC recurrence in patients post-ablation and identify imaging hallmarks of recurrence. METHODS: 53 patients >8 months post ablation of RCC provided informed consent for this IRB approved study. Patients received 2D and 3D CEUS examinations with Optison (GE Healthcare). Three radiologists of varying CEUS experience described enhancement characteristics, made a diagnosis of recurrence/no-recurrence, and quantified their diagnostic confidence levels. RESULTS: Cases of RCC recurrence showed full ablation cavity enhancement with equal arrival times and intensity compared to the renal cortex. Lack of recurrence was characterized as a complete lack of enhancement within the cavity, or delayed enhancement stemming from the periphery of the ablation cavity. Sensitivity for detecting RCC recurrence was 100% for all readers and specificity was 90%-94%. Reader agreement ranged from 88% to 96%. No significant improvements were achieved with the addition of 3D CEUS, and its inclusion resulted in decreased reader confidence. CONCLUSION: Contrast-enhanced ultrasound successfully identified all cases of RCC recurrence in this study. Importantly, some patients with complete response to treatment developed delayed enhancement at the periphery of the ablation cavity over time, corresponding to fat necrosis, scarring or granulation tissue within the ablation cavity.
引用
- Calio BP, Lyshchik A, Li J, et al. Long Term Surveillance of Renal Cell Carcinoma Recurrence Following Ablation using 2D and 3D Contrast-Enhanced Ultrasound. Urology. 2018. PMID: 30384977. doi:10.1016/j.urology.2018.05.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。